5 Must-Haves From Your Peptide Building Block Supplier

Following the massive success of GLP-1 drugs, peptide therapeutics are experiencing unprecedented demand, due to their ability to target specific locations in the body, resulting in fewer side effects and improved safety. While peptides serve as the building blocks of GLP-1 drugs and other therapies, they too are made up of their own smaller components, which can include naturally occurring amino acids as well as synthetic ones. As a result, their manufacture may require a diverse array of amino acid units, or peptide building blocks.

In the pursuit of manufacturing a high-quality, clinically ready peptide therapeutic, sponsors cannot underestimate the importance of partnering with a capable, reliable peptide building block supplier. An experienced partner will offer a wealth of regulatory knowledge, synthetic expertise, scale-up capabilities, and quality assurance. To help protect your supply, process, and ultimately, your product, build your vendor checklist with the following must-haves in mind.

1. U.S.- Based Manufacturing Capabilities and Regulatory Knowledge

Historically, peptide raw materials have been sourced from suppliers in Asia. Amid growing concerns about supply chain resilience, geopolitical uncertainty, and evolving regulatory requirements, many manufacturers are reevaluating their reliance on overseas suppliers in favor of exploring domestic sourcing options. One challenge is that U.S.-based suppliers are currently limited, and often, far more costly than Asia-based suppliers. However, finding a qualified onshore supplier is a huge advantage, affording supply chain reliability and relevant regulatory knowledge. Domestic sourcing provides immense value, including advantages such as greater supply continuity, reduced logistics risk, and closer alignment with U.S. regulatory expectations. 

At Grace’s Fine Chemicals Manufacturing Services’ (FCMS) Tyrone, Pennsylvania site, our team has robust experience manufacturing regulatory starting materials (RSMs) for API products, including the protected amino acids essential to peptide therapeutics. Tyrone is a non-GMP site; however, Grace Subject Matter Experts (SMEs) are deeply knowledgeable of the regulatory requirements for peptide components, including impurity control and consistency expectations. Our long-term RSM expertise and commitment to compliance enable us to manufacture these products in accordance with the most up-to-date regulatory guidelines.

2. Robust Experience and Subject Matter Expertise

While the human body relies on 20 canonical amino acids, countless synthetic amino acids have been developed to introduce properties such as extended half-life, enhanced potency, and improved oral bioavailability. Whether your peptide requires naturally occurring or synthetic amino acids, prioritize suppliers with the technical expertise to reliably manufacture complex building blocks at the required scale.

Grace’s team has worked across a wide range of chemistries and assembled different unit operations to deliver distinct types of amino acids. We are committed to understanding the specific reaction conditions and protecting groups needed to reach a new synthetic target. Our expertise can help accelerate customer timelines. 

In some cases, we have implemented new technologies to improve product isolation, including filtration approaches that enable us to conduct more challenging isolations. These technologies are supported by predictive models that help determine how materials will behave during isolation and filtration. Our ability to leverage these methods is a result of site-to-site collaboration between our Tyrone teams and those at our cGMP site in South Haven, Michigan. 

3. Commitment to Impurity Control and Analytic Excellence

The goal of peptide building block manufacturing is to generate a crystalline material that can be efficiently filtered and purified. However, peptide building blocks present several purification challenges. Without a proper approach, these materials can demonstrate undesirable physical properties that result in slow filtration with poor impurity rejection, putting product quality at risk. 

Our goal is to manufacture protected amino acids for customers that maintain an easy-to-filter crystalline structure, facilitating impurity removal during processing. We have identified conditions that favor these crystals and reduce the risk of slow-filtering physical properties. As a result, we have optimized our manufacturing process to improve impurity rejection and streamline isolation. We offer a deep understanding of what leads to impurity formation, which impurity control tactics mitigate them, and which analytical methods can best track them. 

Our analytical method development team is committed to robustness and repeatability in executing scientifically sound and reliable assays for RSMs. We continuously review analytical data to verify instrument performance and uphold target regulatory standards. When analytical challenges arise, we readily adapt our approach to minimize delays and maintain data integrity. Furthermore, our quality assurance team audits our data to ensure we are on track to deliver intended quality goals. 

4. Flexibility, Reliability, and Adaptive Approaches

The need for raw material supply fluctuates as demand and processes shift. Ensuring that your raw material supplier can scale supply alongside your program is critical. At Grace, longstanding manufacturing knowledge allows us to quickly synthesize peptide building blocks for reliable on-time delivery. This manufacturing experience also supports consistent batch-to-batch performance. 

We employ a wide range of equipment, including different reactor sizes designed to handle the same synthesis from pilot scale to production scale in metric tons. Our Tyrone plant is designed to quickly adjust production schedules as customer priorities evolve. As part of our commitment to supply continuity, our experts are prepared to adapt if a customer’s timeline shifts or scale changes so we can fulfill shifting customer needs and reliably delivery raw material supply. 

We also foster close relationships with our own suppliers to protect supply chain reliability. Our sourcing team qualifies multiple suppliers of essential raw materials and is in regular communication to understand their lead times and delivery schedules. 

5. Collaboration and Communication

At Grace, we prioritize collaboration and communication both internally and externally. Our clients have ongoing access to our team of SMEs, including chemists, engineers, quality experts, and site operations leaders. We work with our customers to determine their preferred communication cadence and provide routine updates on how processes are running. These discussions also serve as an opportunity for customers to ask questions and make requests, such as scale or timeline changes, as well as for us to gain insight into the details of their manufacturing process. 

From an internal perspective, our teams collaborate daily across the Tyrone site, working to troubleshoot any issues that arise. We also regularly rely on the insight of the teams at our GMP sister site in South Haven. 

While peptide building block synthesis may appear straightforward, successful manufacturing depends on careful control of process parameters, quality attributes, and impurity profiles. Transparency across all stakeholders is how our team gathers a deep understanding of a customer’s drug manufacturing process, necessary parameters, and impurity control requirements so that we understand how to deliver the raw materials needed to manufacture a high-quality peptide.

Leverage These Assets to Your Advantage

Whether you are just entering the peptide market or scaling an established program, access to a reliable supply of high-quality building blocks is critical to successful peptide development and manufacturing. Before choosing your manufacturing partner, consider whether they offer U.S.-based manufacturing and regulatory knowledge; deep technical expertise; proven impurity control and analytical capabilities; operational flexibility and reliability; and a commitment to collaboration and communication.  Together, these “must-haves” help protect supply continuity, support quality, and reduce risk throughout the manufacturing process. Grace’s FCMS team brings these capabilities together to help customers mitigate delays and provide continuous access to the building blocks that support consistent, scalable peptide manufacturing.